Ana María López Estévez

Employment

• ICMAB-CSIC Postdoctoral researcher
  2026 - Present
• Italian Institute of Technology Postdoctoral researcher
  2024 - 2026
• Universidade de Santiago de Compostela Postdoctoral researcher at María José Alonso's Lab
  2023 - 2024
• King's College London Visiting PhD candidate
  2022 - 2022
• Universidade de Santiago de Compostela PhD candidate
  2018 - 2023

Education

• University of Santiago de Compostela PhD in Drug Research and Development
  2018 - 2023
• Hospital Universitario Nuestra Señora de Candelaria Pharmacy Intern
  2017 - 2018
• Universidad de La Laguna MSc in Pharmacy
  2013 - 2018
• Pharmacy Sara del Pilar Ramos Linares Pharmacy Intern
  ? - 2018

Projects & Funding

Projects & funding information is unavailable.

Publications (12)

• aCD47–docetaxel immuno-chemotherapy: A two-pronged attack against ‘cold’ glioblastoma
  Journal of Controlled Release 2026 DOI: 10.1016/j.jconrel.2026.115194
  +Save
• Liposomal Delivery of L‐2‐Hydroxyglutarate for Targeting Epigenetic Dysregulation in Osteoarthritis
  Advanced NanoBiomed Research 2026 DOI: 10.1002/anbr.202500250
  +Save
• ARNm y nanotecnología: el futuro de las vacunas y la medicina de precisión
  Ambiociencias 2026 DOI: 10.18002/ambioc.i23.9515
  +Save
• Nanoassemblies for oral protein delivery — The case of monoclonals for inflammatory bowel disease
  Journal of Controlled Release 2026 DOI: 10.1016/j.jconrel.2025.114455
  +Save
• Delivery of monoclonal antibodies to the brain: the impact of nanocarrier structure
  Drug Delivery and Translational Research 2025 DOI: 10.1007/s13346-025-01957-y
  +Save
• Biodistribution of 89Zr-Radiolabeled Nanoassemblies for Monoclonal Antibody Delivery Revealed through In Vivo PET Imaging
  ACS Omega 2025 DOI: 10.1021/acsomega.4c09823
  +Save
• Nanotechnology-assisted intracellular delivery of antibody as a precision therapy approach for KRAS-driven tumors
  Journal of Controlled Release 2024 DOI: 10.1016/j.jconrel.2024.07.032
  +Save
• Engineering hyaluronic acid-based nanoassemblies for monoclonal antibody delivery – design, characterization, and biological insights
  Nano Research 2024 DOI: 10.1007/s12274-024-6826-8
  +Save
• A journey through the history of PEGylated drug delivery nanocarriers
  Drug Delivery and Translational Research 2024 DOI: 10.1007/s13346-024-01608-8
  +Save
• Personalized Cancer Nanomedicine: Overcoming Biological Barriers for Intracellular Delivery of Biopharmaceuticals
  Advanced Materials 2024 DOI: 10.1002/adma.202309355
  +Save